-
公开(公告)号：US10456396B2
公开(公告)日：2019-10-29
申请号：US15422382
申请日：2017-02-01
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K9/00 , A61K31/439 , A61K31/4439 , A61K31/4427 , A61K31/4985 , A61K45/06 , A61K9/08
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
公开(公告)号：US20250000861A1
公开(公告)日：2025-01-02
申请号：US18825758
申请日：2024-09-05
Applicant: Oyster Point Pharma, Inc.
IPC: A61K31/506 , A61K9/00 , A61K31/436 , A61K38/13 , A61K45/06 , A61P27/04
Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions.
-
公开(公告)号：US11903942B2
公开(公告)日：2024-02-20
申请号：US18125517
申请日：2023-03-23
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K31/4439 , A61K45/06 , A61K9/00 , A61K31/439 , A61K31/4427 , A61K9/08 , A61K31/4985
CPC classification number: A61K31/4995 , A61K9/007 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
公开(公告)号：US11224598B2
公开(公告)日：2022-01-18
申请号：US16566237
申请日：2019-09-10
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K31/4439 , A61K45/06 , A61K9/00 , A61K31/439 , A61K31/4427 , A61K9/08 , A61K31/4985
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
公开(公告)号：US11911380B2
公开(公告)日：2024-02-27
申请号：US18125551
申请日：2023-03-23
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K31/4439 , A61K45/06 , A61K9/00 , A61K31/439 , A61K31/4427 , A61K9/08 , A61K31/4985
CPC classification number: A61K31/4995 , A61K9/007 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
Patent Agency Ranking
公开(公告)号：US11903943B2
公开(公告)日：2024-02-20
申请号：US18125562
申请日：2023-03-23
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K31/4439 , A61K45/06 , A61K9/00 , A61K31/439 , A61K31/4427 , A61K9/08 , A61K31/4985
CPC classification number: A61K31/4995 , A61K9/007 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
公开(公告)号：US09504644B2
公开(公告)日：2016-11-29
申请号：US14887243
申请日：2015-10-19
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K9/00 , A61K31/439 , A61K31/4439 , A61K31/4427 , A61K31/4985 , A61K45/06 , A61K31/4995
CPC classification number: A61K31/4995 , A61K9/0043 , A61K9/007 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for increasing tear production.
Abstract translation: 本文描述了用于增加泪液生产的方法和药物制剂。
-
公开(公告)号：US11903941B2
公开(公告)日：2024-02-20
申请号：US17543505
申请日：2021-12-06
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, Jr. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K31/4439 , A61K45/06 , A61K9/00 , A61K31/439 , A61K31/4427 , A61K9/08 , A61K31/4985
CPC classification number: A61K31/4995 , A61K9/007 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
公开(公告)号：US10709707B2
公开(公告)日：2020-07-14
申请号：US16091830
申请日：2017-04-06
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann , James Loudin , Kenneth J. Mandell
IPC: A61K31/506 , A61K9/00 , A61K38/13 , A61K31/436 , A61P27/04 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions.
-
公开(公告)号：US20170239244A1
公开(公告)日：2017-08-24
申请号：US15422382
申请日：2017-02-01
Applicant: Oyster Point Pharma, Inc.
Inventor： Douglas Michael Ackermann, JR. , James Loudin , Kenneth J. Mandell
IPC: A61K31/4995 , A61K45/06 , A61K9/00
CPC classification number: A61K31/4995 , A61K9/0043 , A61K9/0048 , A61K9/007 , A61K9/08 , A61K31/439 , A61K31/4427 , A61K31/4439 , A61K31/4985 , A61K45/06
Abstract: Described herein are methods and pharmaceutical formulations for treating dry eye disease.
-
-
-
-
-
-
-
-
-
Search Results
13
records
(took 0.013 seconds)
